Neuroligin 2 deletion alters inhibitory synapse function and anxiety-associated neuronal activation in the amygdala

Neuropharmacology

Volumn 100, Issue , 2016, Pages 56-65

  Babaev, Olga ^a   Botta, Paolo ^b   Meyer, Elisabeth ^b   Müller, Christian ^b   Ehrenreich, Hannelore ^a   Brose, Nils ^a   Lüthi, Andreas ^b   Krueger Burg, Dilja ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Amygdala; Anxiety; cFos; Gephyrin; Inhibitory synapse; Neuroligins

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; NEUROLIGIN; NEUROLIGIN 2; PROTEIN C FOS; UNCLASSIFIED DRUG; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BASAL AMYGDALA; BRAIN REGION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; MOUSE; NERVE CELL NETWORK; NERVE STIMULATION; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; AMYGDALA; ANIMAL; C57BL MOUSE; GENETICS; INHIBITORY POSTSYNAPTIC POTENTIAL; KNOCKOUT MOUSE; METABOLISM; MINIATURE ENDPLATE POTENTIAL; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SYNAPSE;

AMYGDALA; ANIMALS; ANXIETY; CELL ADHESION MOLECULES, NEURONAL; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MINIATURE POSTSYNAPTIC POTENTIALS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; SYNAPSES;

EID: 84942364573     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.06.016     Document Type: Article

References (31)

1. J. Blundell, K. Tabuchi, M.F. Bolliger, C.A. Blaiss, N. Brose, X. Liu, T.C. Sudhof, and C.M. Powell Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2 Genes Brain Behav. 8 2009 114 126
2. R.J. Braga, G.P. Reynolds, and S.G. Siris Anxiety comorbidity in schizophrenia Psychiat. Res. 210 2013 1 7
3. A.M. Craig, and Y. Kang Neurexin-neuroligin signaling in synapse development Curr. Opin. Neurobiol. 17 2007 43 52
4. I. Ehrlich, Y. Humeau, F. Grenier, S. Ciocchi, C. Herry, and A. Luthi Amygdala inhibitory circuits and the control of fear memory Neuron 62 2009 757 771
5. C. Foldy, R.C. Malenka, and T.C. Sudhof Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling Neuron 78 2013 498 509
6. J.R. Gibson, K.M. Huber, and T.C. Sudhof Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons J. Neurosci. 29 2009 13883 13897
7. E.R. Graf, X. Zhang, S.X. Jin, M.W. Linhoff, and A.M. Craig Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins Cell 119 2004 1013 1026
8. M. Hoon, G. Bauer, J.M. Fritschy, T. Moser, B.H. Falkenburger, and F. Varoqueaux Neuroligin 2 controls the maturation of GABAergic synapses and information processing in the retina J. Neurosci. 29 2009 8039 8050
9. P. Jedlicka, M. Hoon, T. Papadopoulos, A. Vlachos, R. Winkels, A. Poulopoulos, H. Betz, T. Deller, N. Brose, F. Varoqueaux, and S.W. Schwarzacher Increased dentate gyrus excitability in neuroligin-2-deficient mice in vivo Cereb. Cortex 21 2011 357 367
10. D.D. Krueger, L.P. Tuffy, T. Papadopoulos, and N. Brose The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses Curr. Opin. Neurobiol. 22 2012 412 422
11. D.A. Lewis, A.A. Curley, J.R. Glausier, and D.W. Volk Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia Trends Neurosci. 35 2012 57 67
12. A. Luthi, and C. Luscher Pathological circuit function underlying addiction and anxiety disorders Nat. Neurosci. 17 2014 1635 1643
13. R. Macdonald, and J.L. Barker Benzodiazepines specifically modulate GABA-mediated postsynaptic inhibition in cultured mammalian neurones Nature 271 1978 563 564
14. J.F. Muller, F. Mascagni, and A.J. McDonald Coupled networks of parvalbumin-immunoreactive interneurons in the rat basolateral amygdala J. Neurosci. 25 2005 7366 7376
15. J.F. Muller, F. Mascagni, and A.J. McDonald Pyramidal cells of the rat basolateral amygdala: synaptology and innervation by parvalbumin-immunoreactive interneurons J. Comp. Neurol. 494 2006 635 650
16. P. Panzanelli, B.G. Gunn, M.C. Schlatter, D. Benke, S.K. Tyagarajan, P. Scheiffele, D. Belelli, J.J. Lambert, U. Rudolph, and J.M. Fritschy Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells J. Physiol. 589 2011 4959 4980
17. A. Poulopoulos, G. Aramuni, G. Meyer, T. Soykan, M. Hoon, T. Papadopoulos, M. Zhang, I. Paarmann, C. Fuchs, K. Harvey, P. Jedlicka, S.W. Schwarzacher, H. Betz, R.J. Harvey, N. Brose, W. Zhang, and F. Varoqueaux Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin Neuron 63 2009 628 642
18. P.E. Rothwell, M.V. Fuccillo, S. Maxeiner, S.J. Hayton, O. Gokce, B.K. Lim, S.C. Fowler, R.C. Malenka, and T.C. Sudhof Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors Cell 158 2014 198 212
19. S.M. Sagar, F.R. Sharp, and T. Curran Expression of c-fos protein in brain: metabolic mapping at the cellular level Science 240 1988 1328 1331
20. P. Sah, E.S. Faber, M. Lopez De Armentia, and J. Power The amygdaloid complex: anatomy and physiology Physiol. Rev. 83 2003 803 834
21. N. Singewald, P. Salchner, and T. Sharp Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs Biol. Psychiat. 53 2003 275 283
22. T. Soykan, D. Schneeberger, G. Tria, C. Buechner, N. Bader, D. Svergun, I. Tessmer, A. Poulopoulos, T. Papadopoulos, F. Varoqueaux, H. Schindelin, and N. Brose A conformational switch in collybistin determines the differentiation of inhibitory postsynapses EMBO J. 33 2014 2113 2133
23. J. Spampanato, J. Polepalli, and P. Sah Interneurons in the basolateral amygdala Neuropharmacology 60 2011 765 773
24. T.C. Sudhof Neuroligins and neurexins link synaptic function to cognitive disease Nature 455 2008 903 911
25. C. Sun, M.-C. Cheng, R. Qin, D.-L. Liao, T.-T. Chen, F.-J. Koong, G. Chen, and C.-H. Chen Identification and functional characterization of rare mutations of the neuroligin-2 gene (NLGN2) associated with schizophrenia Hum. Mol. Genet. 20 2011 3042 3051
26. K.M. Tye, R. Prakash, S.Y. Kim, L.E. Fenno, L. Grosenick, H. Zarabi, K.R. Thompson, V. Gradinaru, C. Ramakrishnan, and K. Deisseroth Amygdala circuitry mediating reversible and bidirectional control of anxiety Nature 471 2011 358 362
27. F. Varoqueaux, G. Aramuni, R.L. Rawson, R. Mohrmann, M. Missler, K. Gottmann, W. Zhang, T.C. Sudhof, and N. Brose Neuroligins determine synapse maturation and function Neuron 51 2006 741 754
28. F. Varoqueaux, S. Jamain, and N. Brose Neuroligin 2 is exclusively localized to inhibitory synapses Eur. J. Cell Biol. 83 2004 449 456
29. M. Wohr, J.L. Silverman, M.L. Scattoni, S.M. Turner, M.J. Harris, R. Saxena, and J.N. Crawley Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2 Behav. Brain Res. 251 2013 50 64
30. S.B. Wolff, J. Grundemann, P. Tovote, S. Krabbe, G.A. Jacobson, C. Muller, C. Herry, I. Ehrlich, R.W. Friedrich, J.J. Letzkus, and A. Luthi Amygdala interneuron subtypes control fear learning through disinhibition Nature 509 2014 453 458
31. A.R. Woodruff, and P. Sah Networks of parvalbumin-positive interneurons in the basolateral amygdala J. Neurosci. 27 2007 553 563